The use of medication against attention deficit/hyperactivity disorder in Denmark: a drug use study from a patient perspective

No abstract is available for this paper.

• Publication year

  2012

• Venue

  European Journal of Clinical Pharmacology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00228-012-1344-0PMID 22811260
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prevention and intervention

  2013cited by this paper
• The use of medication against attention deficit hyperactivity disorder in Denmark: a drug use study from a national perspective

  2012cited by this paper
• Comorbidities in an asthma population 8–29 years old: a study from the Norwegian Prescription Database

  2012cited by this paper
• Medication use and spending trends among children with ADHD in Florida's Medicaid program, 1996-2005.

  2012cited by this paper
• Acute and chronic methylphenidate alters prefrontal cortex neuronal activity recorded from freely behaving rats.

  2012cited by this paper
• Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs.

  2012cited by this paper
• The use of medication against attention deficit/hyperactivity disorder in Denmark: a drug use study from a patient perspective

  2012cited by this paper
• Behavioral sensitization and cross-sensitization between methylphenidate amphetamine, and 3,4-methylenedioxymethamphetamine (MDMA) in female SD rats.

  2011cited by this paper
• Use of ADHD drugs in the Nordic countries: a population‐based comparison study

  2011cited by this paper
• Pharmacological treatment for Attention Deficit Hyperactivity Disorder (ADHD) in children with comorbid tic disorders.

  2011cited by this paper
• The Danish National Prescription Registry

  2011cited by this paper
• Health Care Transition for Youth Living With HIV/AIDS

  2011cited by this paper
• Sleep disturbances in children with attention-deficit/hyperactivity disorder

  2011cited by this paper
• The occurrence of adverse drug reactions reported for attention deficit hyperactivity disorder (ADHD) medications in the pediatric population: a qualitative review of empirical studies

  2011cited by this paper
• Treatment experiences of children and adolescents with attention‐deficit/hyperactivity disorder

  2011cited by this paper
• European guidelines on managing adverse effects of medication for ADHD

  2010cited by this paper
• Adherence challenges in the management of type 1 diabetes in adolescents: prevention and intervention

  2010cited by this paper
• Treatment of Preschoolers with Attention-Deficit/Hyperactivity Disorder

  2010cited by this paper
• The changing prevalence of attention-deficit/hyperactivity disorder and methylphenidate prescriptions: a study of data from a random sample of insurees of the AOK Health Insurance Company in the German State of Hesse, 2000-2007.

  2010cited by this paper
• National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996-2007.

  2010influential reference
• National trends in psychotropic medication polypharmacy in office-based psychiatry.

  2010influential reference
• Sleep Problems in the Child with Attention-Deficit Hyperactivity Disorder

  2010cited by this paper
• The Meaning of Attention-Deficit/Hyperactivity Disorder Medication and Parents' Initiation and Continuity of Treatment for Their Child

  2009cited by this paper
• Parental Angst Making and Revisiting Decisions About Treatment of Attention-Deficit/Hyperactivity Disorder

  2009cited by this paper
• Large increase of the use of psycho-stimulants among youth in the Netherlands between 1996 and 2006.

  2009cited by this paper
• Efficacy and Safety Limitations of Attention-Deficit Hyperactivity Disorder Pharmacotherapy in Children and Adults

  2009cited by this paper
• Methylphenidate for the treatment of depressive symptoms, including fatigue and apathy, in medically ill older adults and terminally ill adults.

  2009cited by this paper
• Switching from Neurostimulant Therapy to Atomoxetine in Children and Adolescents with Attention-Deficit Hyperactivity Disorder

  2008cited by this paper
• Age of methylphenidate treatment initiation in children with ADHD and later substance abuse: prospective follow-up into adulthood.

  2008cited by this paper
• Tactile and visual hallucinations in a child with methylphenidate and fluoxetine combination.

  2008cited by this paper
• Evidence, Interpretation, and Qualification From Multiple Reports of Long-Term Outcomes in the Multimodal Treatment Study of Children With ADHD (MTA)

  2008cited by this paper
• Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature.

  2008cited by this paper
• Parental attitudes and involvement in psychopharmacological treatment for ADHD: A conceptual model

  2008cited by this paper
• [Use of methylphenidate among children in Iceland 1989-2006].

  2007cited by this paper
• Acute dyskinesia on starting methylphenidate after risperidone withdrawal.

  2007cited by this paper
• Assessment of Pharmacokinetics and Pharmacodynamic Effects Related to Abuse Potential of a Unique Oral Osmotic‐Controlled Extended‐Release Methylphenidate Formulation in Humans

  2007cited by this paper
• [Prescribing of stimulants for ADHD in Nordland County].

  2007cited by this paper
• Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder.

  2007cited by this paper
• A pilot study for augmenting atomoxetine with methylphenidate: safety of concomitant therapy in children with attention-deficit/hyperactivity disorder

  2007cited by this paper
• Epidemiology of attention-deficit/hyperactivity disorder across the lifespan

  2007influential reference
• Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.

  2007cited by this paper
• Dystonia with combined antipsychotic and stimulant treatment.

  2007cited by this paper
• Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder.

  2007cited by this paper
• Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit / Hyperactivity Disorder

  2007cited by this paper
• Recent trends in stimulant medication use among U.S. children.

  2006cited by this paper
• Evidence-Based Assessment of Attention Deficit Hyperactivity Disorder in Children and Adolescents

  2005cited by this paper
• Peer-Assessed Outcomes in the Multimodal Treatment Study of Children With Attention Deficit Hyperactivity Disorder

  2005cited by this paper
• Stimulant-atypical antipsychotic interaction and acute dystonia.

  2005cited by this paper
• National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder.

  2004cited by this paper
• Attention-Deficit/Hyperactivity Disorder in Adults

  2004cited by this paper
• Does stimulant therapy of attention‐deficit/hyperactivity disorder beget later substance abuse?

  2003cited by this paper
• Prevalence of narcolepsy symptomatology and diagnosis in the European general population

  2002cited by this paper
• MTA Study has flaws.

  2001cited by this paper
• Long-term stimulant treatment of children with attention-deficit hyperactivity disorder symptoms. A randomized, double-blind, placebo-controlled trial.

  1997cited by this paper
• The Waiting Time Distribution as a Graphical Approach to Epidemiologic Measures of Drug Utilization

  1997cited by this paper

• Drug survival and risk factors for ADHD medication discontinuation in adults: A Danish Nationwide Registry‐based cohort study

  2024cites this paper
• Dose titration of osmotic release oral system methylphenidate in children and adolescents with attention-deficit hyperactivity disorder: a retrospective cohort study

  2023cites this paper
• [Increasing methylphenidate abuse: Tracking and profiles during 13-years].

  2022cites this paper
• Persistence and adherence to non-vitamin K antagonist oral anticoagulant treatment in patients with atrial fibrillation across five Western European countries

  2021cites this paper
• Combined Medication with Stimulants and Non-stimulants for Attention-deficit/hyperactivity Disorder

  2021cites this paper
• Trends, geographical variation and factors associated with melatonin prescribing in general practices in England: A practice‐level analysis

  2021cites this paper
• Methylphenidate for attention-deficit/hyperactivity disorder in adults: a narrative review

  2021cites this paper
• Genetic, Clinical, and Sociodemographic Factors Associated With Stimulant Treatment Outcomes in ADHD.

  2021cites this paper
• Treatment of ADHD in adults – prevalence of discontinuation and associated factors – results from a cross-sectional analysis of Danish register data

  2020influential citation
• Word count: 5661 words Treatment of ADHD in adults – prevalence of discontinuation and associated factors – results from a cross-sectional analysis of Danish register data Authors:

  2020influential citation
• Comparison of Drugs Prescribed by Psychiatrists and Child/Adolescent Psychiatrists

  2020cites this paper
• Association between methylphenidate treatment and risk of seizure: a population-based, self-controlled case-series study.

  2020cites this paper
• The definition and measurement of heterogeneity

  2020cites this paper
• Bias in case‐crossover studies of medications due to persistent use: A simulation study

  2020cites this paper
• Prevalence, Patient Characteristics, and Pharmacological Treatment of Children, Adolescents, and Adults Diagnosed With ADHD in Sweden

  2018cites this paper
• Patterns and profiles of methylphenidate use both in children and adults

  2018cites this paper
• Use of attention‐deficit/hyperactivity disorder medication among older adults in Denmark

  2018cites this paper
• Estimated prevalence and incidence of diagnosed ADHD and health care utilization in adults in Sweden – a longitudinal population-based register study

  2018cites this paper
• Use of Psychotropic Drugs among Children and Adolescents with Autism Spectrum Disorders in Denmark: A Nationwide Drug Utilization Study

  2018cites this paper
• Blood pressure in children with attention deficit/hyperactivity disorder.

  2018cites this paper
• Overuse of methylphenidate: an analysis of Swedish pharmacy dispensing data

  2018cites this paper
• Maternal and neonatal outcomes after exposure to ADHD medication during pregnancy: A systematic review and meta‐analysis

  2018cites this paper
• Circumstances of prescriptions for ADHD treatment and concurrent medication in juveniles and adults at a psychiatric institution in Japan

  2017cites this paper
• Methylphenidate: Gender trends in adult and pediatric populations over a 7year period.

  2017cites this paper
• Prescribing patterns for attention deficit hyperactivity disorder medications among children and adolescents in Korea, 2007-2011

  2016cites this paper
• Attention Deficit Hyperactivity Disorder Treatment Practice in Turkey

  2016cites this paper
• PT556. A Case Report of Atomoxetine Related Liver Injury in A Child with Attention Deficit/Hyperactivity Disorder, Autistic Spectrum Disorder and Epilepsy

  2016cites this paper
• Differences in Utilization Patterns among Medications in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: a 36-Month Retrospective Study Using the Korean Health Insurance Review and Assessment Claims Database

  2016cites this paper
• Initiation and Persistence of Pharmacotherapy for Youths with Attention Deficit Hyperactivity Disorder in Taiwan

  2016cites this paper
• New Techniques of Difference: On Data as School Pupils

  2016cites this paper
• Factors affecting treatment adherence to atomoxetine in ADHD: a systematic review

  2016cites this paper
• Deviant patterns of methylphenidate use in adults: a Danish nationwide registry‐based drug utilization study

  2015cites this paper
• Patterns of Methylphenidate Use and Assessment of Its Abuse among the General Population and Individuals with Drug Dependence

  2015cites this paper
• [Not Available].

  2015cites this paper
• Early Discontinuation of Attention‐Deficit/Hyperactivity Disorder Drug Treatment: A Danish Nationwide Drug Utilization Study

  2015cites this paper
• Combined methylphenidate and atomoxetine pharmacotherapy in attention deficit hyperactivity disorder

  2015cites this paper
• Example of an investigation of an "emergent" phenomenon in addiction vigilance: the case of methylphenidate.

  2015cites this paper
• Safety and Tolerability of Lisdexamfetamine: A Retrospective Cohort Study

  2015cites this paper
• Adverse pregnancy outcomes after exposure to methylphenidate or atomoxetine during pregnancy

  2015cites this paper
• The Effect of Medical Treatment of Attention Deficit Hyperactivity Disorder (ADHD) on Foster Care Caseloads

  2015cites this paper
• Off-label prescribing of psychotropic drugs in a Danish child and adolescent psychiatric outpatient clinic

  2015cites this paper
• Use of SSRIs among Danish children: a nationwide study

  2014cites this paper
• Medical Treatment of Children and Youths with Attention-Deficit/Hyperactivity Disorder (ADHD): A Norwegian Prescription Registry Based Study

  2014influential citation
• Early Discontinuation of ADHD Drug Treatment : A Danish Nationwide Drug Utilization Study

  2014cites this paper
• A Nationwide Study of Attention‐Deficit/Hyperactivity Disorder Drug Use among Adults in Iceland 2003–2012

  2014cites this paper
• Adherence, persistence, and medication discontinuation in patients with attention-deficit/hyperactivity disorder – a systematic literature review

  2014cites this paper
• Use of ADHD medication during pregnancy from 1999 to 2010: a Danish register‐based study

  2014cites this paper
• Children's relative age in class and use of medication for ADHD: a Danish Nationwide Study

  2014cites this paper
• Treatment Adherence of Osmotic-Controlled Release Oral Delivery System Methylphenidate in Korean Children and Adolescents with Attention-Deficit Hyperactivity Disorder

  2014cites this paper
• Children and youth in behavioural and emotional difficulties, skyrocketing diagnosis and inclusion/exclusion processes in school tendencies in Denmark

  2014cites this paper
• Concomitant Pharmacotherapy of Psychotropic Medications in EU Children and Adolescents with Attention-Deficit/Hyperactivity Disorder

  2013cites this paper
• The use of medication against attention deficit/hyperactivity disorder in Denmark: a drug use study from a patient perspective

  2012cites this paper
• Attention deficit hyperactivity disorder in adults

  2010cites this paper